Cargando…
Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?
Cardiovascular diseases remain an important cause of morbi-mortality. Atherosclerosis, which predisposes to cardiovascular disorders such as myocardial infarction and stroke, develops silently over several decades. Identification of circulating biomarkers to evaluate cardiovascular event risk and pa...
Autores principales: | Baron, Morgane, Boulanger, Chantal M, Staels, Bart, Tailleux, Anne, Simionescu, M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823207/ https://www.ncbi.nlm.nih.gov/pubmed/22050954 http://dx.doi.org/10.1111/j.1582-4934.2011.01486.x |
Ejemplares similares
-
Bone Marrow p16(INK4a)-Deficiency Does Not Modulate Obesity, Glucose Homeostasis or Atherosclerosis Development
por: Wouters, Kristiaan, et al.
Publicado: (2012) -
Mechanical forces stimulate endothelial microparticle generation via caspase-dependent apoptosis-independent mechanism
por: Vion, Anne Clémence, et al.
Publicado: (2013) -
Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism
por: Gillard, Justine, et al.
Publicado: (2022) -
E-selectin-targeting delivery of microRNAs by microparticles ameliorates endothelial inflammation and atherosclerosis
por: Ma, Shuangtao, et al.
Publicado: (2016) -
Endothelial Microparticles in Uremia: Biomarkers and Potential Therapeutic Targets
por: Favretto, Giane, et al.
Publicado: (2019)